Prescription Drug Misuse Remains at Alarming Levels|
Thursday, April 04, 2013
Quest Diagnostics Health Trends™ analysis of a quarter million test results finds three out of five Americans tested misused their prescription medications.
Unanticipated Consequences of DNA Hypomethylation; Loss and Gain of Polycomb Mediated Transcription Repression in Somatic Cells
Monday, April 01, 2013
By genome-wide mapping of the Polycomb Repressive Complex 2 (PRC2)-signature histone mark, H3K27me3, in DNA methylation-deficient mouse somatic cells, the Meehan lab shows that loss of DNA methylation is coincident with widespread H3K27me3 redistribution.
Medicyte GmbH Signs Agreement with Life Technologies to Develop Next Generation Upcyte® Cells
Thursday, March 28, 2013
Medicyte to develop and market next generation, cell-based upcyte® cell products to the biopharma and academic research markets.
RBCC Forms Joint Venture with Cutting-Edge Drug Delivery Company TheraKine
Thursday, March 21, 2013
As part of a bold expansion into the $60 billion global drug delivery market, Rainbow BioSciences announced it has formed a new partnership to solve the problems posed by systemic drug delivery.
Yale Researchers Trick Bacteria to Deliver a Safer Vaccine
Tuesday, March 19, 2013
Yale researchers have developed a new trick, using bacteria’s own cellular mistakes to deliver a safe vaccine.
Trackable Drug-Filled Nanoparticles - a Potential Weapon against Cancer
Monday, March 04, 2013
Tiny particles filled with a drug could be a new tool for treating cancer in the future.
Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine
Thursday, February 28, 2013
We present a case of a young female patient taking atomoxetine irregularly whose urine drug screen returned as a false-positive amphetamine result that was not confirmed.
Phenomenex Launches Innovative, Industry-Focused Websites
Friday, February 22, 2013
Company builds on award-winning web presence with new digital experience.
CiToxLAB Group Increases Revenue by 25 Per Cent over Full Year of 2012
Thursday, February 21, 2013
Despite a stuttering outsourced preclinical development market, the global expansion of the CiToxLAB Group has attracted more clients.